BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29900663)

  • 1. Four times cancer.
    Rosendaal FR; Reitsma PH
    J Thromb Haemost; 2018 Jul; 16(7):1255. PubMed ID: 29900663
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban with or without aspirin for prevention of cardiovascular disease.
    Kruger PC; Eikelboom JW; Yusuf S
    Coron Artery Dis; 2018 Aug; 29(5):361-365. PubMed ID: 29346127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombosis and cancer. An update of our knowledge].
    Tumori; 2006; 92(5):23-41. PubMed ID: 17168451
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer-associated thrombosis: the when, how and why.
    Fernandes CJ; Morinaga LTK; Alves JL; Castro MA; Calderaro D; Jardim CVP; Souza R
    Eur Respir Rev; 2019 Mar; 28(151):. PubMed ID: 30918022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Algorithm for the management of antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention: an updated proposal based on efficacy considerations.
    Rubboli A; Lip GYH
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):197-198. PubMed ID: 31942967
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic therapy in 2017: Advances in atherosclerosis, atrial fibrillation, and valvular disease.
    Bhatt DL
    Nat Rev Cardiol; 2018 Feb; 15(2):71-72. PubMed ID: 29297509
    [No Abstract]   [Full Text] [Related]  

  • 7. Quick reference guide to the new oral anticoagulants.
    Hurst K; Lee R; Handa A
    J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions-Part II: Recommendations: Endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe.
    Patel IJ; Rahim S; Davidson JC; Hanks SE; Tam AL; Walker TG; Wilkins LR; Sarode R; Weinberg I
    J Vasc Interv Radiol; 2019 Aug; 30(8):1168-1184.e1. PubMed ID: 31229333
    [No Abstract]   [Full Text] [Related]  

  • 9. No risk, no benefit: still true for antithrombotic stroke treatments?
    Minnerup J; Kleinschnitz C
    Future Med Chem; 2013 Mar; 5(4):377-9. PubMed ID: 23495684
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombotic agents and invasive procedures--hematologist point of view.
    Lecompte TP
    Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.
    Aronis KN; Hylek EM
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374049
    [No Abstract]   [Full Text] [Related]  

  • 12. The Evolution of Antithrombotic Care in Cardiovascular Patients.
    Camm AJ
    Thromb Haemost; 2018 May; 118(S 01):S1. PubMed ID: 29566412
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of race and gender on antithrombotic therapy.
    Capodanno D; Angiolillo DJ
    Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase treatment of venous thromboembolism: advanced therapy. Systemic fibrinolysis and pharmacomechanical therapy.
    Konstantinides SV; WÃĪrntges S
    Thromb Haemost; 2015 Jun; 113(6):1202-9. PubMed ID: 25789580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XI as a Therapeutic Target.
    Gailani D; Gruber A
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1316-22. PubMed ID: 27174099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric transplantation: preventing thrombosis.
    Robertson JD
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S351-61. PubMed ID: 26149047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.
    Samuelson Bannow BT; Lee A; Khorana AA; Zwicker JI; Noble S; Ay C; Carrier M
    J Thromb Haemost; 2018 Jun; 16(6):1246-1249. PubMed ID: 29737593
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of coagulation abnormalities in liver disease.
    Potze W; Porte RJ; Lisman T
    Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):103-14. PubMed ID: 24970667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC.
    Tardy B; Chalayer E; Kamphuisen PW; Ni Ainle F; Verhamme P; Varlet MN; Chauleur C; Rodger M; Merah A; Buchmuller A; Bistervels I; De Sancho MT; Middeldorp S; Bertoletti L;
    J Thromb Haemost; 2019 Nov; 17(11):1979-1988. PubMed ID: 31402557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.